Global Needle-Free Drug Injection Systems Market Research Report 2024(Status and Outlook)
Report Overview
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
This report provides a deep insight into the global Needle-Free Drug Injection Systems market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Needle-Free Drug Injection Systems Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Needle-Free Drug Injection Systems market in any manner.
Global Needle-Free Drug Injection Systems Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Market Segmentation (by Type)
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Market Segmentation (by Application)
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Needle-Free Drug Injection Systems Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
This report provides a deep insight into the global Needle-Free Drug Injection Systems market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Needle-Free Drug Injection Systems Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Needle-Free Drug Injection Systems market in any manner.
Global Needle-Free Drug Injection Systems Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Market Segmentation (by Type)
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Market Segmentation (by Application)
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Needle-Free Drug Injection Systems Market
- Overview of the regional outlook of the Needle-Free Drug Injection Systems Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Needle-Free Drug Injection Systems Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Needle-Free Drug Injection Systems
1.2 Key Market Segments
1.2.1 Needle-Free Drug Injection Systems Segment by Type
1.2.2 Needle-Free Drug Injection Systems Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Needle-Free Drug Injection Systems Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Needle-Free Drug Injection Systems Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET COMPETITIVE LANDSCAPE
3.1 Global Needle-Free Drug Injection Systems Sales by Manufacturers (2019-2024)
3.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Manufacturers (2019-2024)
3.3 Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Needle-Free Drug Injection Systems Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Needle-Free Drug Injection Systems Sales Sites, Area Served, Product Type
3.6 Needle-Free Drug Injection Systems Market Competitive Situation and Trends
3.6.1 Needle-Free Drug Injection Systems Market Concentration Rate
3.6.2 Global 5 and 10 Largest Needle-Free Drug Injection Systems Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEEDLE-FREE DRUG INJECTION SYSTEMS INDUSTRY CHAIN ANALYSIS
4.1 Needle-Free Drug Injection Systems Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
6.3 Global Needle-Free Drug Injection Systems Market Size Market Share by Type (2019-2024)
6.4 Global Needle-Free Drug Injection Systems Price by Type (2019-2024)
7 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Needle-Free Drug Injection Systems Market Sales by Application (2019-2024)
7.3 Global Needle-Free Drug Injection Systems Market Size (M USD) by Application (2019-2024)
7.4 Global Needle-Free Drug Injection Systems Sales Growth Rate by Application (2019-2024)
8 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET SEGMENTATION BY REGION
8.1 Global Needle-Free Drug Injection Systems Sales by Region
8.1.1 Global Needle-Free Drug Injection Systems Sales by Region
8.1.2 Global Needle-Free Drug Injection Systems Sales Market Share by Region
8.2 North America
8.2.1 North America Needle-Free Drug Injection Systems Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Needle-Free Drug Injection Systems Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Needle-Free Drug Injection Systems Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Needle-Free Drug Injection Systems Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Needle-Free Drug Injection Systems Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Antares Pharma, Inc. (US)
9.1.1 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Basic Information
9.1.2 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Overview
9.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Market Performance
9.1.4 Antares Pharma, Inc. (US) Business Overview
9.1.5 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems SWOT Analysis
9.1.6 Antares Pharma, Inc. (US) Recent Developments
9.2 Endo International plc (US)
9.2.1 Endo International plc (US) Needle-Free Drug Injection Systems Basic Information
9.2.2 Endo International plc (US) Needle-Free Drug Injection Systems Product Overview
9.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Product Market Performance
9.2.4 Endo International plc (US) Business Overview
9.2.5 Endo International plc (US) Needle-Free Drug Injection Systems SWOT Analysis
9.2.6 Endo International plc (US) Recent Developments
9.3 PharmaJet (U.S)
9.3.1 PharmaJet (U.S) Needle-Free Drug Injection Systems Basic Information
9.3.2 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Overview
9.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.3.4 PharmaJet (U.S) Needle-Free Drug Injection Systems SWOT Analysis
9.3.5 PharmaJet (U.S) Business Overview
9.3.6 PharmaJet (U.S) Recent Developments
9.4 Bioject Medical Technologies Inc. (U.S)
9.4.1 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
9.4.2 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
9.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.4.4 Bioject Medical Technologies Inc. (U.S) Business Overview
9.4.5 Bioject Medical Technologies Inc. (U.S) Recent Developments
9.5 Medical International Technology, Inc. (U.S)
9.5.1 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
9.5.2 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
9.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.5.4 Medical International Technology, Inc. (U.S) Business Overview
9.5.5 Medical International Technology, Inc. (U.S) Recent Developments
9.6 INJEX Pharma AG (Germany)
9.6.1 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Basic Information
9.6.2 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Overview
9.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Market Performance
9.6.4 INJEX Pharma AG (Germany) Business Overview
9.6.5 INJEX Pharma AG (Germany) Recent Developments
9.7 National Medical Products Inc. (US)
9.7.1 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Basic Information
9.7.2 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Overview
9.7.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Market Performance
9.7.4 National Medical Products Inc. (US) Business Overview
9.7.5 National Medical Products Inc. (US) Recent Developments
9.8 Valeritas, Inc. (US)
9.8.1 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Basic Information
9.8.2 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Overview
9.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Market Performance
9.8.4 Valeritas, Inc. (US) Business Overview
9.8.5 Valeritas, Inc. (US) Recent Developments
9.9 European Pharma Group (Netherland)
9.9.1 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Basic Information
9.9.2 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Overview
9.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Market Performance
9.9.4 European Pharma Group (Netherland) Business Overview
9.9.5 European Pharma Group (Netherland) Recent Developments
9.10 PenJet Corporation (U.S)
9.10.1 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Basic Information
9.10.2 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Overview
9.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.10.4 PenJet Corporation (U.S) Business Overview
9.10.5 PenJet Corporation (U.S) Recent Developments
9.11 Crossject SA (France)
9.11.1 Crossject SA (France) Needle-Free Drug Injection Systems Basic Information
9.11.2 Crossject SA (France) Needle-Free Drug Injection Systems Product Overview
9.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Product Market Performance
9.11.4 Crossject SA (France) Business Overview
9.11.5 Crossject SA (France) Recent Developments
10 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET FORECAST BY REGION
10.1 Global Needle-Free Drug Injection Systems Market Size Forecast
10.2 Global Needle-Free Drug Injection Systems Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Needle-Free Drug Injection Systems Market Size Forecast by Country
10.2.3 Asia Pacific Needle-Free Drug Injection Systems Market Size Forecast by Region
10.2.4 South America Needle-Free Drug Injection Systems Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Needle-Free Drug Injection Systems by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Needle-Free Drug Injection Systems Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Needle-Free Drug Injection Systems by Type (2025-2030)
11.1.2 Global Needle-Free Drug Injection Systems Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Needle-Free Drug Injection Systems by Type (2025-2030)
11.2 Global Needle-Free Drug Injection Systems Market Forecast by Application (2025-2030)
11.2.1 Global Needle-Free Drug Injection Systems Sales (K Units) Forecast by Application
11.2.2 Global Needle-Free Drug Injection Systems Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Needle-Free Drug Injection Systems
1.2 Key Market Segments
1.2.1 Needle-Free Drug Injection Systems Segment by Type
1.2.2 Needle-Free Drug Injection Systems Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Needle-Free Drug Injection Systems Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Needle-Free Drug Injection Systems Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET COMPETITIVE LANDSCAPE
3.1 Global Needle-Free Drug Injection Systems Sales by Manufacturers (2019-2024)
3.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Manufacturers (2019-2024)
3.3 Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Needle-Free Drug Injection Systems Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Needle-Free Drug Injection Systems Sales Sites, Area Served, Product Type
3.6 Needle-Free Drug Injection Systems Market Competitive Situation and Trends
3.6.1 Needle-Free Drug Injection Systems Market Concentration Rate
3.6.2 Global 5 and 10 Largest Needle-Free Drug Injection Systems Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEEDLE-FREE DRUG INJECTION SYSTEMS INDUSTRY CHAIN ANALYSIS
4.1 Needle-Free Drug Injection Systems Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
6.3 Global Needle-Free Drug Injection Systems Market Size Market Share by Type (2019-2024)
6.4 Global Needle-Free Drug Injection Systems Price by Type (2019-2024)
7 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Needle-Free Drug Injection Systems Market Sales by Application (2019-2024)
7.3 Global Needle-Free Drug Injection Systems Market Size (M USD) by Application (2019-2024)
7.4 Global Needle-Free Drug Injection Systems Sales Growth Rate by Application (2019-2024)
8 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET SEGMENTATION BY REGION
8.1 Global Needle-Free Drug Injection Systems Sales by Region
8.1.1 Global Needle-Free Drug Injection Systems Sales by Region
8.1.2 Global Needle-Free Drug Injection Systems Sales Market Share by Region
8.2 North America
8.2.1 North America Needle-Free Drug Injection Systems Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Needle-Free Drug Injection Systems Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Needle-Free Drug Injection Systems Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Needle-Free Drug Injection Systems Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Needle-Free Drug Injection Systems Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Antares Pharma, Inc. (US)
9.1.1 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Basic Information
9.1.2 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Overview
9.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Market Performance
9.1.4 Antares Pharma, Inc. (US) Business Overview
9.1.5 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems SWOT Analysis
9.1.6 Antares Pharma, Inc. (US) Recent Developments
9.2 Endo International plc (US)
9.2.1 Endo International plc (US) Needle-Free Drug Injection Systems Basic Information
9.2.2 Endo International plc (US) Needle-Free Drug Injection Systems Product Overview
9.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Product Market Performance
9.2.4 Endo International plc (US) Business Overview
9.2.5 Endo International plc (US) Needle-Free Drug Injection Systems SWOT Analysis
9.2.6 Endo International plc (US) Recent Developments
9.3 PharmaJet (U.S)
9.3.1 PharmaJet (U.S) Needle-Free Drug Injection Systems Basic Information
9.3.2 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Overview
9.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.3.4 PharmaJet (U.S) Needle-Free Drug Injection Systems SWOT Analysis
9.3.5 PharmaJet (U.S) Business Overview
9.3.6 PharmaJet (U.S) Recent Developments
9.4 Bioject Medical Technologies Inc. (U.S)
9.4.1 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
9.4.2 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
9.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.4.4 Bioject Medical Technologies Inc. (U.S) Business Overview
9.4.5 Bioject Medical Technologies Inc. (U.S) Recent Developments
9.5 Medical International Technology, Inc. (U.S)
9.5.1 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
9.5.2 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
9.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.5.4 Medical International Technology, Inc. (U.S) Business Overview
9.5.5 Medical International Technology, Inc. (U.S) Recent Developments
9.6 INJEX Pharma AG (Germany)
9.6.1 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Basic Information
9.6.2 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Overview
9.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Market Performance
9.6.4 INJEX Pharma AG (Germany) Business Overview
9.6.5 INJEX Pharma AG (Germany) Recent Developments
9.7 National Medical Products Inc. (US)
9.7.1 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Basic Information
9.7.2 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Overview
9.7.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Market Performance
9.7.4 National Medical Products Inc. (US) Business Overview
9.7.5 National Medical Products Inc. (US) Recent Developments
9.8 Valeritas, Inc. (US)
9.8.1 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Basic Information
9.8.2 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Overview
9.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Market Performance
9.8.4 Valeritas, Inc. (US) Business Overview
9.8.5 Valeritas, Inc. (US) Recent Developments
9.9 European Pharma Group (Netherland)
9.9.1 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Basic Information
9.9.2 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Overview
9.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Market Performance
9.9.4 European Pharma Group (Netherland) Business Overview
9.9.5 European Pharma Group (Netherland) Recent Developments
9.10 PenJet Corporation (U.S)
9.10.1 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Basic Information
9.10.2 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Overview
9.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Market Performance
9.10.4 PenJet Corporation (U.S) Business Overview
9.10.5 PenJet Corporation (U.S) Recent Developments
9.11 Crossject SA (France)
9.11.1 Crossject SA (France) Needle-Free Drug Injection Systems Basic Information
9.11.2 Crossject SA (France) Needle-Free Drug Injection Systems Product Overview
9.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Product Market Performance
9.11.4 Crossject SA (France) Business Overview
9.11.5 Crossject SA (France) Recent Developments
10 NEEDLE-FREE DRUG INJECTION SYSTEMS MARKET FORECAST BY REGION
10.1 Global Needle-Free Drug Injection Systems Market Size Forecast
10.2 Global Needle-Free Drug Injection Systems Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Needle-Free Drug Injection Systems Market Size Forecast by Country
10.2.3 Asia Pacific Needle-Free Drug Injection Systems Market Size Forecast by Region
10.2.4 South America Needle-Free Drug Injection Systems Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Needle-Free Drug Injection Systems by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Needle-Free Drug Injection Systems Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Needle-Free Drug Injection Systems by Type (2025-2030)
11.1.2 Global Needle-Free Drug Injection Systems Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Needle-Free Drug Injection Systems by Type (2025-2030)
11.2 Global Needle-Free Drug Injection Systems Market Forecast by Application (2025-2030)
11.2.1 Global Needle-Free Drug Injection Systems Sales (K Units) Forecast by Application
11.2.2 Global Needle-Free Drug Injection Systems Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Needle-Free Drug Injection Systems Market Size Comparison by Region (M USD)
Table 5. Global Needle-Free Drug Injection Systems Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Needle-Free Drug Injection Systems Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Needle-Free Drug Injection Systems Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Needle-Free Drug Injection Systems Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-Free Drug Injection Systems as of 2022)
Table 10. Global Market Needle-Free Drug Injection Systems Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Needle-Free Drug Injection Systems Sales Sites and Area Served
Table 12. Manufacturers Needle-Free Drug Injection Systems Product Type
Table 13. Global Needle-Free Drug Injection Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Needle-Free Drug Injection Systems
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Needle-Free Drug Injection Systems Market Challenges
Table 22. Global Needle-Free Drug Injection Systems Sales by Type (K Units)
Table 23. Global Needle-Free Drug Injection Systems Market Size by Type (M USD)
Table 24. Global Needle-Free Drug Injection Systems Sales (K Units) by Type (2019-2024)
Table 25. Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Table 26. Global Needle-Free Drug Injection Systems Market Size (M USD) by Type (2019-2024)
Table 27. Global Needle-Free Drug Injection Systems Market Size Share by Type (2019-2024)
Table 28. Global Needle-Free Drug Injection Systems Price (USD/Unit) by Type (2019-2024)
Table 29. Global Needle-Free Drug Injection Systems Sales (K Units) by Application
Table 30. Global Needle-Free Drug Injection Systems Market Size by Application
Table 31. Global Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 32. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Table 33. Global Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (M USD)
Table 34. Global Needle-Free Drug Injection Systems Market Share by Application (2019-2024)
Table 35. Global Needle-Free Drug Injection Systems Sales Growth Rate by Application (2019-2024)
Table 36. Global Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 37. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2019-2024)
Table 38. North America Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 39. Europe Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 41. South America Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 43. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Basic Information
Table 44. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Overview
Table 45. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Antares Pharma, Inc. (US) Business Overview
Table 47. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems SWOT Analysis
Table 48. Antares Pharma, Inc. (US) Recent Developments
Table 49. Endo International plc (US) Needle-Free Drug Injection Systems Basic Information
Table 50. Endo International plc (US) Needle-Free Drug Injection Systems Product Overview
Table 51. Endo International plc (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Endo International plc (US) Business Overview
Table 53. Endo International plc (US) Needle-Free Drug Injection Systems SWOT Analysis
Table 54. Endo International plc (US) Recent Developments
Table 55. PharmaJet (U.S) Needle-Free Drug Injection Systems Basic Information
Table 56. PharmaJet (U.S) Needle-Free Drug Injection Systems Product Overview
Table 57. PharmaJet (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. PharmaJet (U.S) Needle-Free Drug Injection Systems SWOT Analysis
Table 59. PharmaJet (U.S) Business Overview
Table 60. PharmaJet (U.S) Recent Developments
Table 61. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
Table 62. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
Table 63. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bioject Medical Technologies Inc. (U.S) Business Overview
Table 65. Bioject Medical Technologies Inc. (U.S) Recent Developments
Table 66. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
Table 67. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
Table 68. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Medical International Technology, Inc. (U.S) Business Overview
Table 70. Medical International Technology, Inc. (U.S) Recent Developments
Table 71. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Basic Information
Table 72. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Overview
Table 73. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. INJEX Pharma AG (Germany) Business Overview
Table 75. INJEX Pharma AG (Germany) Recent Developments
Table 76. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Basic Information
Table 77. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Overview
Table 78. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. National Medical Products Inc. (US) Business Overview
Table 80. National Medical Products Inc. (US) Recent Developments
Table 81. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Basic Information
Table 82. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Overview
Table 83. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Valeritas, Inc. (US) Business Overview
Table 85. Valeritas, Inc. (US) Recent Developments
Table 86. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Basic Information
Table 87. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Overview
Table 88. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. European Pharma Group (Netherland) Business Overview
Table 90. European Pharma Group (Netherland) Recent Developments
Table 91. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Basic Information
Table 92. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Overview
Table 93. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. PenJet Corporation (U.S) Business Overview
Table 95. PenJet Corporation (U.S) Recent Developments
Table 96. Crossject SA (France) Needle-Free Drug Injection Systems Basic Information
Table 97. Crossject SA (France) Needle-Free Drug Injection Systems Product Overview
Table 98. Crossject SA (France) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Crossject SA (France) Business Overview
Table 100. Crossject SA (France) Recent Developments
Table 101. Global Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Needle-Free Drug Injection Systems Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Needle-Free Drug Injection Systems Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Needle-Free Drug Injection Systems Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Needle-Free Drug Injection Systems Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Needle-Free Drug Injection Systems Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Needle-Free Drug Injection Systems Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Needle-Free Drug Injection Systems Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Needle-Free Drug Injection Systems Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Needle-Free Drug Injection Systems Market Size Comparison by Region (M USD)
Table 5. Global Needle-Free Drug Injection Systems Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Needle-Free Drug Injection Systems Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Needle-Free Drug Injection Systems Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Needle-Free Drug Injection Systems Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-Free Drug Injection Systems as of 2022)
Table 10. Global Market Needle-Free Drug Injection Systems Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Needle-Free Drug Injection Systems Sales Sites and Area Served
Table 12. Manufacturers Needle-Free Drug Injection Systems Product Type
Table 13. Global Needle-Free Drug Injection Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Needle-Free Drug Injection Systems
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Needle-Free Drug Injection Systems Market Challenges
Table 22. Global Needle-Free Drug Injection Systems Sales by Type (K Units)
Table 23. Global Needle-Free Drug Injection Systems Market Size by Type (M USD)
Table 24. Global Needle-Free Drug Injection Systems Sales (K Units) by Type (2019-2024)
Table 25. Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Table 26. Global Needle-Free Drug Injection Systems Market Size (M USD) by Type (2019-2024)
Table 27. Global Needle-Free Drug Injection Systems Market Size Share by Type (2019-2024)
Table 28. Global Needle-Free Drug Injection Systems Price (USD/Unit) by Type (2019-2024)
Table 29. Global Needle-Free Drug Injection Systems Sales (K Units) by Application
Table 30. Global Needle-Free Drug Injection Systems Market Size by Application
Table 31. Global Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 32. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Table 33. Global Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (M USD)
Table 34. Global Needle-Free Drug Injection Systems Market Share by Application (2019-2024)
Table 35. Global Needle-Free Drug Injection Systems Sales Growth Rate by Application (2019-2024)
Table 36. Global Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 37. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2019-2024)
Table 38. North America Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 39. Europe Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 41. South America Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 43. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Basic Information
Table 44. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Overview
Table 45. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Antares Pharma, Inc. (US) Business Overview
Table 47. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems SWOT Analysis
Table 48. Antares Pharma, Inc. (US) Recent Developments
Table 49. Endo International plc (US) Needle-Free Drug Injection Systems Basic Information
Table 50. Endo International plc (US) Needle-Free Drug Injection Systems Product Overview
Table 51. Endo International plc (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Endo International plc (US) Business Overview
Table 53. Endo International plc (US) Needle-Free Drug Injection Systems SWOT Analysis
Table 54. Endo International plc (US) Recent Developments
Table 55. PharmaJet (U.S) Needle-Free Drug Injection Systems Basic Information
Table 56. PharmaJet (U.S) Needle-Free Drug Injection Systems Product Overview
Table 57. PharmaJet (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. PharmaJet (U.S) Needle-Free Drug Injection Systems SWOT Analysis
Table 59. PharmaJet (U.S) Business Overview
Table 60. PharmaJet (U.S) Recent Developments
Table 61. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
Table 62. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
Table 63. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bioject Medical Technologies Inc. (U.S) Business Overview
Table 65. Bioject Medical Technologies Inc. (U.S) Recent Developments
Table 66. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Basic Information
Table 67. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Overview
Table 68. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Medical International Technology, Inc. (U.S) Business Overview
Table 70. Medical International Technology, Inc. (U.S) Recent Developments
Table 71. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Basic Information
Table 72. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Overview
Table 73. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. INJEX Pharma AG (Germany) Business Overview
Table 75. INJEX Pharma AG (Germany) Recent Developments
Table 76. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Basic Information
Table 77. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Overview
Table 78. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. National Medical Products Inc. (US) Business Overview
Table 80. National Medical Products Inc. (US) Recent Developments
Table 81. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Basic Information
Table 82. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Overview
Table 83. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Valeritas, Inc. (US) Business Overview
Table 85. Valeritas, Inc. (US) Recent Developments
Table 86. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Basic Information
Table 87. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Overview
Table 88. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. European Pharma Group (Netherland) Business Overview
Table 90. European Pharma Group (Netherland) Recent Developments
Table 91. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Basic Information
Table 92. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Overview
Table 93. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. PenJet Corporation (U.S) Business Overview
Table 95. PenJet Corporation (U.S) Recent Developments
Table 96. Crossject SA (France) Needle-Free Drug Injection Systems Basic Information
Table 97. Crossject SA (France) Needle-Free Drug Injection Systems Product Overview
Table 98. Crossject SA (France) Needle-Free Drug Injection Systems Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Crossject SA (France) Business Overview
Table 100. Crossject SA (France) Recent Developments
Table 101. Global Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Needle-Free Drug Injection Systems Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Needle-Free Drug Injection Systems Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Needle-Free Drug Injection Systems Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Needle-Free Drug Injection Systems Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Needle-Free Drug Injection Systems Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Needle-Free Drug Injection Systems Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Needle-Free Drug Injection Systems Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Needle-Free Drug Injection Systems Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Needle-Free Drug Injection Systems Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Needle-Free Drug Injection Systems
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Needle-Free Drug Injection Systems Market Size (M USD), 2019-2030
Figure 5. Global Needle-Free Drug Injection Systems Market Size (M USD) (2019-2030)
Figure 6. Global Needle-Free Drug Injection Systems Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Needle-Free Drug Injection Systems Market Size by Country (M USD)
Figure 11. Needle-Free Drug Injection Systems Sales Share by Manufacturers in 2023
Figure 12. Global Needle-Free Drug Injection Systems Revenue Share by Manufacturers in 2023
Figure 13. Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Needle-Free Drug Injection Systems Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Needle-Free Drug Injection Systems Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Needle-Free Drug Injection Systems Market Share by Type
Figure 18. Sales Market Share of Needle-Free Drug Injection Systems by Type (2019-2024)
Figure 19. Sales Market Share of Needle-Free Drug Injection Systems by Type in 2023
Figure 20. Market Size Share of Needle-Free Drug Injection Systems by Type (2019-2024)
Figure 21. Market Size Market Share of Needle-Free Drug Injection Systems by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Needle-Free Drug Injection Systems Market Share by Application
Figure 24. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 25. Global Needle-Free Drug Injection Systems Sales Market Share by Application in 2023
Figure 26. Global Needle-Free Drug Injection Systems Market Share by Application (2019-2024)
Figure 27. Global Needle-Free Drug Injection Systems Market Share by Application in 2023
Figure 28. Global Needle-Free Drug Injection Systems Sales Growth Rate by Application (2019-2024)
Figure 29. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2019-2024)
Figure 30. North America Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 32. U.S. Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Needle-Free Drug Injection Systems Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Needle-Free Drug Injection Systems Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 37. Germany Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Needle-Free Drug Injection Systems Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Needle-Free Drug Injection Systems Sales Market Share by Region in 2023
Figure 44. China Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Needle-Free Drug Injection Systems Sales and Growth Rate (K Units)
Figure 50. South America Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 51. Brazil Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Needle-Free Drug Injection Systems Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Needle-Free Drug Injection Systems Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Needle-Free Drug Injection Systems Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Needle-Free Drug Injection Systems Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Needle-Free Drug Injection Systems Market Share Forecast by Type (2025-2030)
Figure 65. Global Needle-Free Drug Injection Systems Sales Forecast by Application (2025-2030)
Figure 66. Global Needle-Free Drug Injection Systems Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Needle-Free Drug Injection Systems
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Needle-Free Drug Injection Systems Market Size (M USD), 2019-2030
Figure 5. Global Needle-Free Drug Injection Systems Market Size (M USD) (2019-2030)
Figure 6. Global Needle-Free Drug Injection Systems Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Needle-Free Drug Injection Systems Market Size by Country (M USD)
Figure 11. Needle-Free Drug Injection Systems Sales Share by Manufacturers in 2023
Figure 12. Global Needle-Free Drug Injection Systems Revenue Share by Manufacturers in 2023
Figure 13. Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Needle-Free Drug Injection Systems Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Needle-Free Drug Injection Systems Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Needle-Free Drug Injection Systems Market Share by Type
Figure 18. Sales Market Share of Needle-Free Drug Injection Systems by Type (2019-2024)
Figure 19. Sales Market Share of Needle-Free Drug Injection Systems by Type in 2023
Figure 20. Market Size Share of Needle-Free Drug Injection Systems by Type (2019-2024)
Figure 21. Market Size Market Share of Needle-Free Drug Injection Systems by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Needle-Free Drug Injection Systems Market Share by Application
Figure 24. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 25. Global Needle-Free Drug Injection Systems Sales Market Share by Application in 2023
Figure 26. Global Needle-Free Drug Injection Systems Market Share by Application (2019-2024)
Figure 27. Global Needle-Free Drug Injection Systems Market Share by Application in 2023
Figure 28. Global Needle-Free Drug Injection Systems Sales Growth Rate by Application (2019-2024)
Figure 29. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2019-2024)
Figure 30. North America Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 32. U.S. Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Needle-Free Drug Injection Systems Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Needle-Free Drug Injection Systems Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 37. Germany Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Needle-Free Drug Injection Systems Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Needle-Free Drug Injection Systems Sales Market Share by Region in 2023
Figure 44. China Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Needle-Free Drug Injection Systems Sales and Growth Rate (K Units)
Figure 50. South America Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 51. Brazil Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Needle-Free Drug Injection Systems Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Needle-Free Drug Injection Systems Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Needle-Free Drug Injection Systems Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Needle-Free Drug Injection Systems Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Needle-Free Drug Injection Systems Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Needle-Free Drug Injection Systems Market Share Forecast by Type (2025-2030)
Figure 65. Global Needle-Free Drug Injection Systems Sales Forecast by Application (2025-2030)
Figure 66. Global Needle-Free Drug Injection Systems Market Share Forecast by Application (2025-2030)
